Goldschmidt-Clermont PJ - Search Results

1

Higher prevalence of GPIIIa PlA2 polymorphism in siblings of patients with premature coronary heart disease.

Goldschmidt-Clermont PJ, Coleman LD, Pham YM, Cooke GE, Shear WS, Weiss EJ, Kral BG, Moy TF, Yook RM, Blumenthal RS, Becker DM, Becker LC, Bray PF. Goldschmidt-Clermont PJ, et al. Arch Pathol Lab Med. 1999 Dec;123(12):1223-9. doi: 10.5858/1999-123-1223-HPOGPA. Arch Pathol Lab Med. 1999. PMID: 10583927 Free article.

2

Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics.

Goldschmidt-Clermont PJ, Roos CM, Cooke GE. Goldschmidt-Clermont PJ, et al. J Thromb Thrombolysis. 1999 Aug;8(2):89-103. doi: 10.1023/a:1008954916972. J Thromb Thrombolysis. 1999. PMID: 10436139 Review. No abstract available.

3

The PlA polymorphism of glycoprotein IIIa functions as a modifier for the effect of estrogen on platelet aggregation.

Boudoulas KD, Cooke GE, Roos CM, Bray PF, Goldschmidt-Clermont PJ. Boudoulas KD, et al. Arch Pathol Lab Med. 2001 Jan;125(1):112-5. doi: 10.5858/2001-125-0112-TPAPOG. Arch Pathol Lab Med. 2001. PMID: 11151063 Free article.

4

A meta-analysis of studies on the association of the platelet PlA polymorphism of glycoprotein IIIa and risk of coronary heart disease.

Burr D, Doss H, Cooke GE, Goldschmidt-Clermont PJ. Burr D, et al. Stat Med. 2003 May 30;22(10):1741-60. doi: 10.1002/sim.1375. Stat Med. 2003. PMID: 12720308

5

Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.

Cooke GE, Liu-Stratton Y, Ferketich AK, Moeschberger ML, Frid DJ, Magorien RD, Bray PF, Binkley PF, Goldschmidt-Clermont PJ. Cooke GE, et al. J Am Coll Cardiol. 2006 Feb 7;47(3):541-6. doi: 10.1016/j.jacc.2005.09.034. Epub 2006 Jan 18. J Am Coll Cardiol. 2006. PMID: 16458133 Free article. Clinical Trial.

6

Estradiol increases platelet aggregation in Pl(A1/A1) individuals.

Boudoulas KD, Montague CR, Goldschmidt-Clermont PJ, Cooke GE. Boudoulas KD, et al. Am Heart J. 2006 Jul;152(1):136-9. doi: 10.1016/j.ahj.2005.07.036. Am Heart J. 2006. PMID: 16824843

7

The safety and efficacy of aspirin and clopidogrel as a combination treatment in patients with coronary heart disease.

Cooke GE, Goldschmidt-Clermont PJ. Cooke GE, et al. Expert Opin Drug Saf. 2006 Nov;5(6):815-26. doi: 10.1517/14740338.5.6.815. Expert Opin Drug Saf. 2006. PMID: 17044808 Review.

8

A polymorphism of a platelet glycoprotein receptor as an inherited risk factor for coronary thrombosis.

Weiss EJ, Bray PF, Tayback M, Schulman SP, Kickler TS, Becker LC, Weiss JL, Gerstenblith G, Goldschmidt-Clermont PJ. Weiss EJ, et al. N Engl J Med. 1996 Apr 25;334(17):1090-4. doi: 10.1056/NEJM199604253341703. N Engl J Med. 1996. PMID: 8598867 Free article.

9

A monoclonal antibody (SZ21) specific for platelet GPIIIa distinguishes P1A1 from P1A2.

Weiss EJ, Goldschmidt-Clermont PJ, Grigoryev D, Jin Y, Kickler TS, Bray PF. Weiss EJ, et al. Tissue Antigens. 1995 Nov;46(5):374-81. doi: 10.1111/j.1399-0039.1995.tb03129.x. Tissue Antigens. 1995. PMID: 8838346

10

PlA2, a variant of GPIIIa implicated in coronary thromboembolic complications.

Goldschmidt-Clermont PJ, Cooke GE, Eaton GM, Binkley PF. Goldschmidt-Clermont PJ, et al. J Am Coll Cardiol. 2000 Jul;36(1):90-3. doi: 10.1016/s0735-1097(00)00710-5. J Am Coll Cardiol. 2000. PMID: 10898418 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

238 results

Search Page

Filters